http://rdf.ncbi.nlm.nih.gov/pubchem/patent/HR-P20080598-T3
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_a6735602cb65a6b6366b446225d0b7f1 |
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P43-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-7068 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-495 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-498 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-513 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-513 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-498 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P35-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-7068 |
| filingDate | 2008-12-02-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_7b27482beaa96022e709d67bacb7c71a |
| publicationDate | 2009-01-31-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | HR-P20080598-T3 |
| titleOfInvention | ET-743 COMBINATION WITH 5-FLUOROURACIL PROCESSES FOR CANCER TREATMENT |
| abstract | The use of ET-743 in combination with a therapeutically effective amount of a 5-fluorouracil prodrug selected from capecitabine or compounds of the formula: wherein each R 1, R 2 and R 3 are independently hydrogen, or a radical that can be easily hydrolyzed under physiological conditions, provided that, at least one of R 1, R 2 or R 3 is a radical that can be easily hydrolyzed under physiological conditions; as well as hydrates or solvates of the compounds of general formula (I); or a compound of formula (II) wherein R 1 is a saturated straight-chain or branched hydrocarbon radical having the number of carbon atoms in the longest straight chain of this hydrocarbon radical in the range of three to seven, or a radical of formula- (CH 2) ny wherein Y is a cyclohexyl radical, C 1 -C 4 alkoxy radical or phenyl radical and wherein, when Y is a cyclohexyl radical, then n is an integer from 0 to 4, and when Y is a C1-C4 alkoxy radical or phenyl radical, then n is an integer from 2 to 4, and R2 is an atom hydrogen or a radical which can be easily hydrolysed under physiological conditions or its hydrates or solvate, for the preparation of a medicament for the treatment of the human organism by cancer. The patent contains another 19 patent claims. |
| priorityDate | 2003-11-13-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 27.